Skip to main content
Retour
Watch Compare

NP Life Sciences Health Industry Group Inc.

Qualité des données : 100%
ACAT
OTC Services Educational Services
1,00 €
▼ 9,00 € (-90,00%)
Cap. Boursière: 77,21 M
Prix
1,00 €
Cap. Boursière
77,21 M
Fourchette du Jour
1,00 € — 1,00 €
Fourchette 52 Semaines
0,54 € — 10,00 €
Volume
2 500
Ouverture 1,00 €
Moyenne 50J / 200J
10,00 €
90,00% below
Moyenne 50J / 200J
6,07 €
83,54% below

Quick Summary

Points Clés

ROE of 58,71% indicates high profitability
Generating 55 238,0 in free cash flow
P/E of 2660,93 — premium valuation
Cash machine — converts 190,36% of earnings into free cash flow
ROIC of 34,16% — excellent capital efficiency

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-38,04%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
58,71%
Au-dessus de la moyenne du secteur (-1,53%)
ROIC34,16%
Net Margin14,46%
Op. Margin25,80%

Sécurité

Debt / Equity
N/A
Current RatioN/A
Interest Coverage12943,00

Valorisation

PE (TTM)
2660,93
Au-dessus de la moyenne du secteur (-0,01)
P/B Ratio2433,04
EV/EBITDA1489,81
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (20 pairs)
Métrique Action Médiane du Secteur
P/E 2660,9 0,0
P/B 2433,0 3,1
ROE % 58,7 -1,5
Net Margin % 14,5 -0,3
Rev Growth 5Y % — 19,1
D/E — 1,0

All Fundamental Metrics
Growth
Revenue Growth (1Y) -38,04% Revenue Growth (3Y) 70,73%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 200 634,0 Net Income (TTM) 29 018,0
ROE 58,71% ROA 24,24%
Gross Margin N/A Operating Margin 25,80%
Net Margin 14,46% Free Cash Flow (TTM) 55 238,0
ROIC 34,16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage 12943,00 Asset Turnover 1,68
Working Capital N/A Tangible Book Value 31 736
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2660,93 Forward P/E N/A
P/B Ratio 2433,04 P/S Ratio 384,85
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1489,81 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,07%
Market Cap 77,21 M Enterprise Value 77,13 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 190,36%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Revenue 102 002,0 164 621,0 34 992,0 15 000,0 43 000,0
Net Income -18 856,0 -2 935,0 -65 677,0 -131 065,0 -108 827,0
EPS (Diluted) — 0,00 — — —
Gross Profit — — — — —
Operating Income -18 855,0 -690,0 -65 681,0 -131 091,0 -108 859,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense -1,0 645,0 — — —
Income Tax — 1 600,0 — — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Total Assets 127 784,0 76 864,0 38 411,0 118 611,0 250 097,0
Total Liabilities 108 468,0 60 483,0 239,0 14 762,0 15 183,0
Shareholders' Equity 19 316,0 16 381,0 38 172,0 103 849,0 234 914,0
Total Debt — — — — —
Cash & Equivalents 121 859,0 70 614,0 27 986,0 118 611,0 242 933,0
Current Assets — — — — —
Current Liabilities — 38 121,0 — — —